Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia
靶向胸腺基质淋巴细胞生成素受体可降低 CRLF2 重排 Ph 样和唐氏综合征急性淋巴细胞白血病的免疫治疗耐药性
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-024-02493-3
Balestra, Tommaso; Niswander, Lisa M; Bagashev, Asen; Loftus, Joseph P; Ross, Savannah L; Chen, Robert K; McClellan, Samantha M; Junco, Jacob J; Bárcenas López, Diego A; Rabin, Karen R; Fry, Terry J; Tasian, Sarah K
CRLF2
信号转导
治疗耐药
白血病
细胞生物学
免疫/内分泌